Most impactful trials in structural heart disease 2024/2025

Anchorperson: M. Alasnag

Spokesperson: H. Al Lawati

Summary

Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing a comprehensive overview of emerging clinical data and future directions.

Learning Objectives

To understand the current dilemmas in TAVI including early TAVI and small annuli
To recognise the current evidence for transcatheter repair of mitral and tricuspid regurgitation
To identify the gaps in evidence for the region

Presentations available when logged in: